The honest menu,
before you decide.
A plain reading of the alternatives to joint replacement: what each option actually does, when it works, when it doesn't, and the questions worth asking your surgeon before you sign the consent form.
PT, cortisone / HA, PRP, MSC therapy, and surgery itself. Each has a role.
Severity, structure, and goals. Without those, option-comparison is noise.
End-stage degeneration, neurologic compromise, mechanical failure. The honest answer.
Every tool
has a window.
None of these options is universally right. Each addresses a different problem, over a different time frame, with different trade-offs. The evaluation is about matching the tool to the structure, not picking a favorite.
Physical therapy & loading programs
Should be the first answer for most joint complaints. Strengthens supporting structures, often reduces symptom severity meaningfully. Doesn't regenerate cartilage.
Cortisone & hyaluronic acid injections
Reduce inflammation and modulate symptoms for weeks to months. Helpful for flare management. Repeated cortisone use accelerates cartilage loss, worth knowing.
PRP (platelet-rich plasma)
Concentrated platelet product delivering growth factors. Reasonable for tendinopathy and mild OA. Limited cartilage effect. Usually cheaper than MSC therapy.
MSC therapy
Allogeneic mesenchymal stem cells delivered to the joint. Paracrine signaling over weeks to months. Legitimate option for moderate OA before bone-on-bone.
Joint replacement
Replace the degenerated structure with hardware. Reliable at the end of the disease curve. Significant recovery. Durable, but not infinite, especially in younger patients.
Which tool
fits the structure.
Mild degeneration, first presentation
Grade I–II OA or early tendinopathy. Symptoms present but structure still largely preserved.
- PT first
- PRP for tendon
- Injection for flare
Moderate, plateaued on conservative
Grade II–III OA with partial joint-space preservation. Surgery has been raised but isn't urgent.
- MSC therapy considered
- PT maintained
- Surgery on the table
End-stage, bone-on-bone
Grade IV OA, subchondral bone loss, mechanical instability. Function severely limited.
- Replacement appropriate
- MSC unlikely to help
- Surgical referral
Five questions
worth asking your surgeon.
If you've been recommended a joint replacement, these five questions sort an "inevitable" recommendation from a conservatively-timed one. Bring this list to your next appointment.
A surgeon worth their credentials welcomes these questions. If any of them are dismissed or deflected, that's information.
You're allowed to take notes. You're allowed to ask for a written copy of the surgical recommendation. You're allowed to take it to another evaluator.
What's my realistic functional outcome?
Not "you'll walk again." Specific return-to-activity and timeline against your own baseline.
What are the complication rates, yours?
Published rates are aggregate. Your individual surgeon's rates for this specific procedure are what matter.
Have I been evaluated for regenerative therapy?
If the answer is "no" or "that doesn't work," ask what criteria were used.
What happens if I wait 6 to 12 months?
Genuine progressive pathology looks different from "now is as good as any." The distinction is worth hearing.
If this doesn't achieve my outcome, what's next?
Revision surgery, conversion procedures, and lifetime hardware management are real considerations, especially if you're under sixty.
Sometimes surgery
is the answer.
We decline more cases than we treat. Patients who have crossed structural thresholds where biology can no longer reach deserve an honest answer, not a sales pitch.
Grade IV osteoarthritis with bone-on-bone contact. Avascular necrosis with subchondral collapse. Massive retracted rotator cuff tears. Spinal instability with neurologic compromise. These are surgical cases, and good surgery is excellent medicine.
The point of the evaluation is to sort which category your case is in, not to funnel everyone into the same treatment.
MSC therapy is not a universal alternative to surgery. It is one option with a specific candidate profile. When surgery is the right call, we will tell you, and refer you to surgeons whose outcomes we trust.
If you're reading marketing that promises regenerative therapy "beats surgery" for every patient, close the tab. That claim is false, and anyone making it is selling you something.
Common
questions.
Q.01Is regenerative therapy always better than surgery?
Q.02Can I do MSC therapy and still have surgery later if needed?
Q.03What about cortisone, is it harmful?
Q.04How do I choose between PRP and MSC therapy?
Keep
reading.
Bring us your
imaging.
The honest answer starts with a physician reading your imaging against your goals. If surgery is right, we'll say so. If MSC therapy is reasonable, we'll explain why.